"Antiemetics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to prevent NAUSEA or VOMITING.
| Descriptor ID |
D000932
|
| MeSH Number(s) |
D27.505.696.663.050.030 D27.505.954.427.095 D27.505.954.483.200
|
| Concept/Terms |
Antiemetics- Antiemetics
- Antiemetic Drugs
- Drugs, Antiemetic
- Anti-emetics
- Anti emetics
- Antiemetic Agents
- Agents, Antiemetic
Antiemetic Effect- Antiemetic Effect
- Effect, Antiemetic
- Anti-Emetic Effects
- Anti Emetic Effects
- Effects, Anti-Emetic
- Antiemetic Effects
- Effects, Antiemetic
- Anti-Emetic Effect
- Anti Emetic Effect
- Effect, Anti-Emetic
|
Below are MeSH descriptors whose meaning is more general than "Antiemetics".
Below are MeSH descriptors whose meaning is more specific than "Antiemetics".
This graph shows the total number of publications written about "Antiemetics" by people in this website by year, and whether "Antiemetics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 |
| 1997 | 2 | 1 | 3 |
| 1998 | 1 | 2 | 3 |
| 1999 | 2 | 0 | 2 |
| 2000 | 2 | 1 | 3 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 3 | 0 | 3 |
| 2004 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 4 | 1 | 5 |
| 2011 | 1 | 3 | 4 |
| 2012 | 3 | 3 | 6 |
| 2013 | 1 | 2 | 3 |
| 2014 | 4 | 0 | 4 |
| 2015 | 2 | 1 | 3 |
| 2016 | 1 | 0 | 1 |
| 2017 | 5 | 2 | 7 |
| 2019 | 1 | 2 | 3 |
| 2020 | 2 | 1 | 3 |
| 2021 | 4 | 0 | 4 |
| 2022 | 3 | 0 | 3 |
| 2023 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antiemetics" by people in Profiles.
-
Antiemetic prophylaxis with droperidol in morphine-based intravenous patient-controlled analgesia: a propensity score matched cohort study. BMC Anesthesiol. 2023 10 28; 23(1):351.
-
A Postoperative Nausea and Vomiting Update: Current information on New Drugs, Old Drugs, Rescue/Treatment, Combination Therapies and Nontraditional Modalities. Adv Anesth. 2023 12; 41(1):17-38.
-
Benefits and risks of off-label olanzapine use for symptom management in cancer patients-a case report. Ann Palliat Med. 2023 May; 12(3):600-606.
-
Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial. Int J Clin Oncol. 2023 Jan; 28(1):163-174.
-
Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer. Support Care Cancer. 2022 Dec 16; 31(1):39.
-
Inhalation of Isopropyl Alcohol for the Management of Nausea and Vomiting: A Systematic Review. J Palliat Med. 2023 01; 26(1):94-100.
-
Supportive care for the prevention of nausea, vomiting and anorexia in a phase 1B study of selinexor in advanced cancer patients: an exploratory study. Invest New Drugs. 2022 02; 40(1):124-133.
-
MASCC antiemetics in advanced cancer updated guideline. Support Care Cancer. 2021 Dec; 29(12):8097-8107.
-
Medical management of malignant bowel obstruction in patients with advanced cancer: 2021 MASCC guideline update. Support Care Cancer. 2021 Dec; 29(12):8089-8096.
-
Fixed-Dose Netupitant and Palonosetron for Chronic Nausea in Cancer Patients: A Double-Blind, Placebo Run-in Pilot Randomized Clinical Trial. J Pain Symptom Manage. 2021 08; 62(2):223-232.e1.